Redwood Pharma

Develops new ophthalmic pharmaceutical therapies where there are large and unmet market needs.

Redwood Pharma´s lead development product is a new therapy for treatment of chronic Dry Eye Disease (DED) in post-menopausal women. With an ageing population, DED affects more and more people hindering many in their daily activities such as reading, using a computer and driving an automobile.